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Abstract
Background
Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults
are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in
urban adult Cameroonians.
Methods
A community-based survey was conducted from December 2013 to April 2014 among
adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel
stratified random sampling across all districts of Yaounde (Capital city). Internationally vali-
dated questionnaires were used to investigate the presence of allergic diseases. Logistic re-
gressions were employed to investigate the determinants of allergic conditions.
Results
Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime
wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4% (10.1-12.7) for self-reported life-
time allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic
rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis. The prevalence of current asthma
medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respec-
tively. Multivariable adjusted determinants of current wheezing were signs of atopic eczema
[2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)]. Age group 31-40 years
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[0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing. Determi-
nants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p<0.001], signs of
atopic eczema [2.84 (1.48-5.46)] and current wheezing [3.02 (1.70-5.39)].
Conclusion
Prevalence rates for asthma and allergic rhinitis among adults in this population were at the
lower tails of those reported in other regions of the world. Beside the classical interrelation
between allergic diseases found in this study, active smoking was an independent determi-
nant of allergic rhinitis symptoms. Nationwide surveys are needed to investigate regional
variations.
Introduction
Allergic respiratory conditions are a major public health challenge worldwide. According to
the World Health Organization (WHO) estimates, about 300 million people around the world
suffer from asthma and about 250,000 people die from the disease each year [1]. Likewise
about 12% to 30% of the population across regions suffer from allergic rhinitis [2]. Although al-
lergic rhinitis is not a fatal condition, it is associated with impaired quality of life, absenteeism
from work and substantial financial costs [3].
Reports from epidemiological studies suggest increases in the prevalence of respiratory al-
lergic diseases in the last decades [4,5]. There has also been improvement in the knowledge re-
garding the risk factors of these diseases which include among others host related factors such
as genetic predisposition, smoking, obesity, hormonal changes, and environmental factors
comprising exposition to aeroallergens, improved hygiene, air pollution and lifestyle changes
with adoption of western diet [6].
In sub-Saharan Africa, little is known on the prevalence of asthma and allergic rhinitis in
adults [7,8]. Furthermore, the few studies published over ten years ago indicate prevalence fig-
ures among adults ranging from 24.4% to 30% for current allergic rhinitis [9,10], and 2% to
12% for current asthma symptoms (wheezing) [11,12,13]. However, the prevalence of self-re-
ported asthma varies from one African country to another. The prevalence of self-reported
asthma in Tanzania, Nigeria and South Africa was 3.3%, 2% and 3.8% respectively [12,13,14].
The only available prevalence study of asthma in adults in Cameroonians was conducted dur-
ing 1996–1997, and reported a prevalence of 1.7% for wheezing in the last 12 months [13]. We
are not aware of existing prevalence studies on allergic rhinitis in Cameroon.
The aim of this study was to assess the prevalence and determinants of asthma and allergic
rhinitis in urban adult Cameroonians.
Material and Methods
Study type and population
This cross-sectional study was conducted in the seven districts of Yaounde, the Capital City of
Cameroon, from December 2013 to April 2014 (five months). Yaounde is situated at about
700–800 m above the sea and had a total population of 2,440,462 inhabitants in 2011 [15].
Consenting adults aged 19 years and above were considered for inclusion in the study[16].
People with hearing and speech problems were excluded.
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Procedures
Sampling. Amultilevel stratified random procedure was used to select participants for in-
clusion in this study. The first level consisted of randomly selecting 16 enumeration areas (EA)
from a total of 2000 in Yaounde, based on a ratio of 2–3 EA per district. EA delineation was
based on the last general population census conducted in Cameroon in 2005[17]. At the second
level one household in two was selected using a systematic sampling (sampling step = 2). The
number of households per EA ranged from 70 to 110. The first household and itinerary fol-
lowed were based on those of the national vaccination campaigns (NVC). At the third level all
adults aged 19 years and above in selected households formed the primary statistical units for
data collection.
Data collection
All consenting participants were included in the study. Data collection used a questionnaire de-
rived from those of the International Study of Asthma and Allergies in Childhood (ISAAC)
[18] and the European Community Respiratory Health Survey II (ECRHS II)[19]. Question-
naires were completed by trained field workers who were all final year undergraduate medial
students. Socio-demographic details included sex, age, marital status, region of origin and eth-
nic group, the highest education level achieved and the number of individuals per bedroom in
the household. Tobacco smoking was assessed and participants ranked as current smokers
(participants who reported having smoked at least one cigarette per day for at least one year, or
having smoked at least 20 cigarettes in their lifetime and was still smoking), ex-smokers (par-
ticipants who declared having stopped smoking for at least six months) and non-smokers[20].
Data collected on asthma and asthma symptoms included: asthma diagnosed by a health
professional, asthma crisis in the last twelve months, chest wheezing at any time, effort related
wheezing, severity of wheezing in the last twelve months (number of wheezing, number of times
awaken by wheezing, wheezing episodes with inability to speak out one or two words consecu-
tively)[18], awakening due to tightness, awakening due to attack of breathless, awakening due to
cough, night-time dry cough in the absence of flu and chest infection, current medication intake
for asthma. Data collected for the diagnosis of allergic rhinitis and rhino-conjunctivitis included:
signs of rhinitis (sneezing, rhinorrhoea, nasal obstruction) in the absence of flu and cold, tears
and itching during rhinitis, impairment of daily life activities due to allergic rhinitis. The pres-
ence of atopic eczema was based on the existence of characteristic symptoms which are « skin
eruptions (reddish papule, swollen spot. . .), which are itching, and appear and disappear inter-
mittently over a period of at least six months ». Height and weight were measured and body
mass index (BMI) derived as weight (kg)/height/height (m2), and BMI>30kg/ m2 used to define
obesity[21].
Operational definitions [18,19]
Lifetime asthma diagnosis (asthma-ever) was based on self-reported diagnosis of asthma by a
health professional during the lifetime of the participant. Current symptoms of asthma were
those experienced in the last 12 months. Rhinitis was defined by sneezing, nasal blockage or
rhinorrhoea at the time the subject did not have cold or flu. Current symptoms of allergic rhini-
tis were those experienced in the last 12 months. Lifetime allergic rhinitis was based on self-re-
ported allergic rhinitis during the lifetime of the participant.
Asthma and Allergic Rhinitis
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Ethics statement
The study was approved by the Ethics Committee of the Faculty of Medicine and Pharmaceuti-
cal Sciences of the Douala University, Cameroon. The study was further approved by the health
authorities of the Centre Region of Cameroon, and signed informed consent obtained from all
included participants.
Statistical Analysis
We have used sample size calculation module of Epi-info software to derive the sample size.
The inflation factor was based on the recruitment of 156 subjects in each enumeration era and
a hypothetical intraclass correlation coefficient (σ) of 0.006 [22]. The design effect or inflation
factor is computed as 1+σ(m-1), where m = 156 is a size of clusters. Thus, the design effect is 2
for this study. Based on an estimated population of 1.4 million inhabitants, considering a prev-
alence of 1.5% for current wheezing, for a precision of 1% and a 95% confidence interval, the
required sample size for the current study was 605 individuals. Considering an inflation factor
of two for the effect of stratification and a non-response rate of 10%, the minimal required
number of participants was 1331.
Data were analysed with the use of IBM-SPSS v.20 for Windows (SPSS Inc., Chicago, IL).
Qualitative data are presented as counts and proportions, and quantitative variables as mean
and standard deviation (SD) or median and 25th-75th percentiles. Chi square test and Fisher
exact test were used to compare proportions. Age-standardized prevalence was calculated
using the Cameroon National population’s age structure in 2010 as the standard population
[23], and direct standardization methods [24]. Logistic regressions models were employed to
investigate the determinants of current wheezing and current allergic rhinitis. Potential deter-
minants were first tested in univariable analysis and significant determinants (based on a
threshold p<0.10) were further tested in multivariable models. A p-value<0.05 was used to
characterise statistically significant results.
Results
General characteristics of the study population
A total of 2,475 participants were invited to take part in the study, of whom 194 declined (re-
sponse rate 93.4%), and survey forms were incomplete for seven other participants. Therefore
2,304 participants were included in the final analytic sample. The characteristics of this sample
are presented in Table 1. In all 1321 (57.3%) were women, mean age (SD) was 34.9 (13.5) years,
and 32% had university education, while 8.4% were current smokers and 5.6% were ex-smokers.
Prevalence of asthma, symptoms of asthma and allergic rhinitis
The prevalence of asthma-ever was 2.7% (95% confidence interval: 2.1–3.4%). A total of 158
participants had had at least an episode of wheezing in their lifetime, giving a prevalence of
6.9% (5.9–7.9) for wheeze-ever. The prevalence of current wheezing was 2.9% (2.2–3.6). The
crude and age-standardised prevalence of symptoms of asthma is found in Table 2. Night-time
awakening by coughing attack was the most frequent symptom with a prevalence of 15.3%
(13.8–16.8), followed by nocturnal dry cough [10.6% (9.3–11.9)]. The prevalence of self-re-
ported lifetime allergic rhinitis was 11.4% (10.1–12.7). Current allergic rhinitis symptoms were
reported by 240 participants (10.4%) and 125 (5.4%) had allergic rhino-conjunctivitis symp-
toms. With the exception of asthma-ever (p = 0.036) and current asthma (p = 0.017), preva-
lence rates were mostly similar in men and women; furthermore, age-standardisation had
meaningless effect on the overall prevalence rates (Table 2).
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Severity of the wheezing and allergic rhinitis
Of the 66 participants with current wheezing, 10.6% had more than 12 episodes of wheezing in
the last 12 months; 12.1% had more than one episode of sleep disturbances per week due to
wheezing, while 43.9% had had severe attacks with inability to say one or two words during
wheezing (Table 3). Of the 306 participants with symptoms of allergic rhinitis who had provid-
ed information on the impact of symptoms on daily life activities, 11 (3.6%) had severe im-
pairment, 14 (4.6%) had moderate impairment, 55 (18%) had mild impairment while 226
(73.9%) had no impairment.
Table 1. Characteristics of study population.
Characteristics Overall Women Men p-value
N 2304 (100%) 1321 (57.3%) 983 (42.7%)
Age, years
Range 19–90 19–87 19–90
Mean (standard deviation) 34.9 (13.5) 35.1 (13.3) 34.6 (13.7) 0.412
Median (25th-75th percentiles) 30 (24–42) 31 (25–43) 30 (24–42)
Level of education
Range 0–22 0–22 0–20
Mean (standard deviation) 11.3 (4.2) 10.6 (4.3) 12.2 (3.9) <0.001
Median(25th-75th percentiles) 12 (8–15) 10 (7–14) 12 (10–15)
 Primary school, n (%) 423/2297 (18.4) 305 (23.1) 118 (12) <0.001
Secondary school, n (%) 1136/2297 (49.5) 657 (49.9) 479 (48.9)
Higher education, n (%) 738/2297 (32.1) 355 (27.0) 383 (39.1)
Ethnic group <0.001
Bantou, n (%) 1191/2291 (52) 704 (53.7) 487 (49.6)
Semi-Bantou, n (%) 970/2291 (42.3) 556 (42.4) 414 (42.2)
Others, n (%) 130/2291 (5.7) 50 (3.8) 80 (8.2)
Marital status 0.014
Living in couple, n (%) 802/2274 (35.3) 488 (37.4) 314 (32.4)
Alone, n (%) 1472/2274 (64.7) 816 (62.6) 656 (67.6)
Number/bedrooms in household
Range 0.3–11 0.3–11.0 0.3–9.0
Mean (standard deviation) 2.4 (1.4) 2.6 (1.4) 2.2 (1.3) <0.001
Median (25th-75th percentiles) 2.1 (1.5–3) 2.2 (1.7–3.0) 2.0 (1.0–2.7)
Tobacco smoking <0.001
Smokers, n (%) 194/2298 (8.4) 36 (2.7) 158 (16.1)
Ex-smokers, n (%) 129/2298 (5.6) 25 (1.9) 104 (10.6)
Non-smokers, n (%) 1975/2298 *85.9) 1257 (95.4) 718 (73.3)
BMI, kg/m2
Range 14.2–60.4 14.2–60.4 15.2–49.9
Mean (standard deviation) 26.5 (5.4) 27.4 (5.9) 25.1 (4.3) <0.001
Median(25th-75th percentiles) 25.3 (22.6–29.4) 26.6 (23.1–30.8) 24.4 (22.2–27.6)
 30, n (%) 502/2280 (22) 379 (29.0) 123 (12.7) <0.001
BMI, body mass index.
doi:10.1371/journal.pone.0123099.t001
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Table 2. Prevalence of asthma, asthma symptoms and rhinitis.
Symptoms Number Crude
prevalence, %
(95% CI)
p
gender
Age Standardized
prevalence, Overall, %
(95% CI)
Age Standardized
prevalence for men, %
(95% CI)
Age Standardized
prevalence for women, %
(95% CI)
Asthma
Asthma ever 65 2.7 (2.1–3.4) 0.036 2.7 (2.0–3.4) 1.6 (0.8–2.4) 3.5 (2.4–4.6)
Current attack of
asthma
24 1 (0.6–1.4) 0.017 1.2 (0.7–1.7) 0.7 (0.2–1.2) 1.6 (0.9–2.3)
Current asthma
medications use
19 0.8 (0.4–1.2) 0.225 0.8 (0.4–1.2) 0.4 (0.0–0.8) 1.2 (0.6–1.8)
Wheezing ever 158 6.9 (5.9–7.9) 0.325 6.9 (5.8–8.0) 6.3 (4.7–7.9) 7.4 (5.9–8.9)
Current wheezing 66 2.9 (2.2–3.6) 0.675 2.9 (2.2–3.6) 2.6 (1.6–3.6) 3.1 (2.1–4.1)
Current wheezing at
effort
62 2.7 (2.0–3.4) 0.611 2.6 (2.0–3.2) 2.3 (1.3–3.3) 2.7 (1.8–3.6)
Current awakening
with tightness
217 9.4 (8.2–10.6) 0.244 9.3 (8.0–10.6) 8.5 (6.6–10.4) 10.1 (8.4–11.8)
Current attack of
breathless
137 5.9 (4.9–6.9) 0.076 6.2 (5.2–7.2) 5.1 (3.6–6.6) 6.8 (5.4–8.2)
Current attack
cough
352 15.3 (13.8–16.8) 0.138 15.2 (13.6–16.8) 13.4 (11.1–15.7) 16.4 (14.2–18.6)
Current nocturnal
cough without cold
245 10.6 (9.3–11.9) 0.685 10.7 (9.3–12.1) 11.0 (8.9–13.1) 10.6 (8.8–12.4)
Rhinitis
Self-reported
allergic rhinitis
262 11.4 (10.1–12.7) 0.247 11.2 (9.8–12.6) 12.1 (9.9–14.3) 10.4 (8.7–12.1)
Rhinitis symptoms
ever
342 14.8 (13.4–16.2) 0.389 14.6 (13.0–16.2) 13.5 (11.2–15.8) 15.3 (13.2–17.4)
Current symptoms
of rhinitis
240 10.4 (9.2–11.6) 0.591 10.3 (9.0–11.6) 9.4 (7.5–11.3) 10.8 (9.0–12.6)
Current rhino-
conjunctivitis
125 5.4 (4.5–6.3) 0.377 5.3 (4.3–6.3) 4.7 (3.3–6.1) 5.8 (4.5–7.1)
CI, conﬁdence interval.
doi:10.1371/journal.pone.0123099.t002
Table 3. Severity of current wheezing.
Severity indices Prevalence, %
Number of wheezing episodes in 12 months
3 80.3
4–12 9.1
> 12 10.6
Sleep disturbed by wheezing
Never 57.6
< 1/week 30.3
 1/week 12.1
Limitation of speech to one or two words during wheezing
Yes 43.9
No 56.1
doi:10.1371/journal.pone.0123099.t003
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Determinants of asthma and allergic rhinitis
In univariable analysis, current wheezing was less frequent in the age group 31–40 years rela-
tive to other age groups. The prevalence of current wheezing by sex and age groups is shown in
Fig 1. Current wheezing was higher in women aged 50 years and above, relative to their male
counterparts (p = 0.128). Current wheezing was found in 7.5% of participants with rhinitis and
in 2.3% of those without rhinitis (p<0.001). The prevalence of current rhinitis was 27.3%
among subjects with current wheezing and 9.9% in those without current wheezing (p<0.001).
Six teen (25.4%) participants with asthma ever had current rhinitis and 10% of participants
without asthma ever had current rhinitis (p<0.001). Likewise, the prevalence of wheezing was
higher in participants with signs of eczema compared to those without (9.4% vs. 2.7%,
p<0.001). Allergic rhinitis was more frequent in participants with university education, in
smokers and participants with wheezing or symptoms of atopic eczema (Table 4).
In multivariable regression analyses (Table 5), significant determinants of current wheezing
were signs of atopic eczema [adjusted odd ratio (95% CI): 2.91 (1.09–7.74), p = 0.033] and
symptoms of allergic rhinitis [3.24 (1.83–5.71), p< 0.001]. Age group 31–40 years [0.27 (0.09–
0.78), p = 0.016] was an independent protective factor for wheezing. Female gender [2.76
(1.51–5.05), p = 0.001] and current rhinitis symptoms [2.99 (1.66–5.39), p<0.001)] were the
Fig 1. Prevalence of current wheezing by age group and gender.
doi:10.1371/journal.pone.0123099.g001
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Table 4. Prevalence and odds ratio of current wheezing and current allergic rhinitis in selected group.
Characteristics Current
wheezing
Asthma
ever
Current
rhinitis
symptoms
Current rhino-
conjunctivitis
symptoms
% COR (95%
CI)
p % COR (95%
CI)
p % COR (95%
CI)
p % COR (95% CI) p
Sex
Female 3 1.15 (0.70–
1.90)
0.589 3.7 2.67(1.46–
4.86)
0.001 10.7 1.09 (0.83–
1.43)
0.504 5.8 1.21(0.83–1.75) 0.322
Male 2.6 1 1.4 1 10 1 4.9 1
Age group, years
19–30 3.3 0.68 (0.30–
1.54)
0.297 3.1 1.1250.39–
3.18)
0.839 11.3 1.40 (0.76–
2.61)
0.282 6.5 1.37(0.62–3.02) 0.443
31–40 1.4 0.29 (0.10–
0.81)
0.018 2.4 0.86(0.27–
2.71)
0.798 9.8 1.20 (0.62–
2.31)
0.597 3.6 0.73(0.30–1.79) 0.492
41–50 3 0.61 (0.22–
1.67)
0.336 3 1.09(0.33–
3.60)
0.888 8.7 1.05 (0.51–
2.15)
0.891 3 0.61(0.22–1.67) 0.336
51–60 2 0.41 (0.12–
1.42)
0.408 1 0.36(0.07–
2.00)
0.243 10.7 1.32 (0.63–
2.78)
0.465 7.7 1.62(0.64–4.09) 0.305
> 60 4.9 1 2.8 1 8.3 1 4.9 1
Level of education
< secondary 3.1 0.94 (0.48–
1.87)
0.867 2.6 0.79(0.39–
1.64)
0.533 9.2 1 5.9 1
secondary 2.6 0.78 (0.45–
1.35)
0.373 2.5 0.75(0.43–
1.31)
0.312 8.8 0.95 (0.65–
1.40)
0.797 4.4 0.86(0.53–1.42) 0.564
Higher education 3.3 1 3.3 1 13.7 1.56 (1.06–
2.31)
0.025 6.8 1.58(1.05–2.36) 0.027
Ethnic group
Bantou 3.2 2.11 (0.50–
8.85)
0.308 3 1.32(0.40–
4.35)
0.648 11 1.89 (0.90–
3.94)
0.092 5.8 1.27(0.54–2.99) 0.582
Semi-Bantou 2.7 1.76 (0.41–
7.52)
0.444 2.4 0.97(0.29–
3.29)
0.964 10.4 1.77 (0.84–
3.73)
0.132 5.2 1.12(0.47–2.67) 0.793
Peul/Sudanese 1.5 1 3 1 6.2 1 4.6 1
Marital status
Living in couple 2.4 1 1.9 1 9 1 4.1 1
Alone 3.2 1.36 (0.79–
2.33)
0.263 3.3 1.77(0.98–
3.18)
0.054 11.3 1.30 (0.97–
1.74)
0.079 6.2 1.54(1.02–2.31) 0.038
Number/chamber
in household
(n = 2232)
 2 3.2 1.29 (0.78–
2.13)
0.321 3 1.27(0.76–
2.12)
0.356 11.2 1.201 (0.92–
1.58)
0.174 5.6 1.06(0.74–1.53) 0.749
> 2 2.5 1 2.4 1 9.5 1 5.3 1
Tobacco smoking
(n = 2298)
smokers 3.1 1.09 (0.39–
3.07)
0.861 1.5 0.51(0.16–
1.64)
0.259 19.4 2.21 (1.39–
3.50)
0.001 8.2 1.70(0.98–2.95) 0.058
Ex-smokers 3.1 1.09 (0.47–
2.57)
0.837 0.8 0.25(0.04–
1.85)
0.176 10.8 1.11 (0.69–
1.80)
0.656 7.8 1.59(0.81–3.13) 0.178
Non-smokers 2.8 1 3 1 9.8 1 5 1
History of
pulmonary TB
Yes 2.2 0.77 (0.10–
5.65)
0.794 4.4 1.68(0.39–
7.08)
0.477 11.1 1.08 (0.42–
2.76)
0.878 2.2 0.39(0.05–2.84) 0.388
(Continued)
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independent determinants of asthma ever. Determinants of rhinitis were current smoking
[2.20 (1.37–3.54), p<0.001], signs of atopic eczema [2.84 (1.48–5.46), p = 0.002] and current
wheezing [3.02 (1.70–5.39), p< 0.001]. Finally, determinants of rhino-conjunctivitis were cur-
rent wheezing [4.06 (2.11–7.81), p<0.001] and atopic eczema [3.53 (1.67–7.47) p = 0.001].
Discussion
The key finding from this first study on the prevalence of allergic rhinitis and asthma among
adults in urban Cameroon are the following: 1) about three percent of this population had cur-
rent wheezing or a self-reported lifetime diagnosis of asthma; 2) about one in ten participants
had symptoms of allergic rhinitis while one in twenty participants had symptoms of rhino-con-
junctivitis; 3) Finally, other allergic conditions were independently associated with asthma and
allergic rhinitis.
The prevalence of asthma and symptoms varies across regions [8,25]. In general, the preva-
lence of self-reported asthma is lower than that for wheezing, the chief symptoms of asthma
used in epidemiological studies. The prevalence of asthma and symptoms is higher in northern
Europe, USA, Australia and New Zealand [25]. The prevalence of current wheezing is as higher
as 32% in these countries and the prevalence of self-reported current asthma as higher as 13%
[25,26]. Contrariwise, prevalence rates are lower in Southern Europe (Italy and Spain) where
Table 4. (Continued)
Characteristics Current
wheezing
Asthma
ever
Current
rhinitis
symptoms
Current rhino-
conjunctivitis
symptoms
No 2.9 1 2.7 1 10.4 1 5.5 1
BMI, kg/
m2(n = 2280)
 30 3 0.96 (0.53–
1.72)
0.88 3.4 1.35(0.77–
2.38)
0.300 10.6 1.04 (0.75–
1.43)
0.834 4.4 0.77(0.48–1.23) 0.276
< 30 2.9 1 2.5 1 10.2 1 5.6 1
Current eczema
symptoms
Yes 9.4 3.74 (1.44–
9.72)
0.016 5.7 2.19(0.67–
7.22)
0.175 26.4 3.22 (1.72–
6.02)
<0.001 18.9 4.32(2.12–8.81) <0.001
No 2.7 1 2.7 1 10 1 5.1 1
Current rhinitis / / / / / /
Yes 7.5 3.41 (1.95–
5.96)
<0.001 6.7 3.07(1.71–
5.50)
<0.001 / / / ./ / /
No 2.3 1 2.3
Current wheezing
Yes / / / 30.3 22.19
(12.11–
40.67)
<0.001 27.3 3.41 (1.95–
5.96)
<0.001 20 4.70(2.49–8.89) <0.001
No / / / 1.9 1 9.9 1 5 1
Asthma ever
Yes 31.7 22.19
(12.11–
40.66)
<0.001 / / / 25.4 3.41 (1.95–
5.96)
<0.001 15.9 3.46(1.71–6.97) <0.001
No 2.1 1 / / / 10 5.2 1
CI, conﬁdence interval; CRO, crude odds ratio; BMI, body mass index; TB, tuberculosis.
doi:10.1371/journal.pone.0123099.t004
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Table 5. Multivariate analysis of factors associated to current wheezing and current rhinitis symptoms in Yaounde, Cameroon.
CURRENT WHEEZING
Factors Adjusted OR (95% CI) p
Age group, years
19–30 0.64(0.28–1.47) 0.290
31–40 0.27(0.09–0.78) 0.016
41–50 0.61(0.22–1.68) 0.340
51–60 0.40(0.11–1.39) 0.149
> 60 1
Eczema symptoms
Yes 2.91(1.09–7.74) 0.033
No 1
Rhinitis
Yes 3.24(1.83–5.71) <0.001
No 1
ASTHMA EVER
Factors
Sex
Female 2.76(1.51–5.05) 0.001
Male 1
Age group, years
19–30 0.89(0.30–2.61) 0.829
31–40 0.81(0.25–2.57) 0.716
41–50 1.17(0.34–3.91) 0.802
51–60 0.37(0.07–2.10) 0.263
> 60 1
Marital status
Living in couple 1
Living alone 1.79(0.94–3.40) 0.078
Current rhinitis symptoms
Yes 2.99(1.66–5.39) <0.001
No 1
CURRENT RHINITIS SYMPTOMS
Factors Adjusted OR (95% CI) p
Level of education
< secondary 1
Secondary 0.92(0.62–1.37) 0.680
Higher education 1.49(1.00–2.23) 0.051
Ethnic group
Bantou 1.72(0.81–3.62) 0.156
Semi-Bantou 1.69(0.80–3.58) 0.170
Peul/Sudanese 1
Marital status
Alone 1,19(0.88–1.62) 0.250
Living in couple 1
Tobacco smoking
Smokers 2.20(1.37–3.54) 0.001
Ex-smokers 1.12(0.69–1.83) 0.646
Non-smokers 1
(Continued)
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prevalence rates for wheezing and self-reported asthma range from 4 to 13.9% and from 2 to
6.6% respectively [25,27]. Significant variations in the prevalence of asthma and symptoms are
strong indicators of the need for locally relevant studies. In our study conducted in a major
sub-Saharan African city, the prevalence of current wheezing was 2.9%. This prevalence is
much lower than those reported in most European countries, but close to rates reported in
most Asian countries [25,28,29].
Very few studies are available on the epidemiology of asthma in sub-Saharan African coun-
tries, particularly in adults. The prevalence of self-reported asthma-ever in our study is close to
that reported in Tanzania (3.3%) [13], Nigeria (2%) [12] and South Africa (3.8%) [14]. Wheez-
ing in the last 12 months was reported by 2.9% of our participants. Rates reported from other
African countries ranged from 1.7% in Ethiopia, 3% in Tanzania, 9% in Nigeria to 16.3% in
South Africa [11,13,14,30]. The prevalence of lifelong wheezing was 6.9% in our participants.
The prevalence of asthma in Yaounde was at the lower tail of figures reported across other re-
gions in the world. In a systematic review conducted by Adeloye et al comprising prevalence
studies on Asthma from Africa published between 1990 and 2013, the estimated overall preva-
lence of asthma (current wheezing) in Africa was 13.8% (95%CI: 6.2–21.4) in people aged 15 to
45 years [8]. This figure is higher than the one reported in our study, and could be explained at
Table 5. (Continued)
CURRENT WHEEZING
Eczema symptoms
Yes 2.84(1.48–5.46) 0.002
No 1
Wheezing
Yes 3.02(1.70–5.39) <0.001
No 1
CURRENT RHINO-CONJUNCTIVITIS
Factors
Level of education
< secondary 1
Secondary 0.70(0.43–1.16) 0.166
Higher education 1.07(0.64–1.79) 0.793
Marital status
Alone 1.45(0.95–2.22) 0.082
Living in couple 1
Tobacco smoking
Smokers 1.64(0.93–2.88) 0.087
Ex-smokers 1.58(0.79–3.19) 0.193
Non-smokers 1
Eczema symptoms
Yes 3.53(1.67–7.47) 0.001
No 1
Wheezing
Yes 4.06(2.11–7.82) <0.001
No 1
OR, odds ratio.
doi:10.1371/journal.pone.0123099.t005
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least in part by the fact that the review by Adeyole et al included more adolescents, with the av-
erage age of 18.4 years.
The main suggested reasons to explain these regional disparities in the prevalence of asthma
include the exposure to environmental factor (climatic variations, exposure to aeroallergens,
air pollution, exposure to micro-organisms), socio-economic factors, and lifestyles [31,32].
Mites’ sensitisation is an important and powerful risk factor of asthma[33]. Sensitisation to
mites is frequent in people with asthma in Yaounde and in other African countries [34,35,36].
The level of this sensitisation is comparable to that reported in most regions of the world
[34,35,36,37] and may therefore not explain the low prevalence of asthma in most African
countries. The low prevalence of smoking found in our study and which has also been reported
in other African countries [12,38], could partially explain the low prevalence of asthma in
Yaounde and across Africa. Other risk factors for asthma such as obesity and low socio-eco-
nomic status [39] were not associated with asthma or wheezing in this study. Complex interac-
tions between environmental factors and host related factors (genetic, comorbidities, lifestyle)
further account for some of the variations in asthma prevalence around the world.
More than 40% of our participants, who had had wheezing in the last 12 months, had severe
wheezing. Of those patients with severe wheezing, less than 1/3rd took asthma medications in
the last 12 months. These results suggest a potentially fatal discrepancy in the management of
people with asthma in this setting. As classically reported, asthma symptoms were more fre-
quent in participants with other allergic conditions [40]. Indeed, participants with current
wheezing were three times more likely to have rhinitis and atopic eczema.
Symptoms of current allergic rhinitis and rhino-conjunctivitis were present in one in ten
and one in twenty participants respectively. Symptoms of allergic rhinitis were less frequent in
our study than in reports from Asia where prevalence ranged from 23.6% to 38% [2,41] and Ni-
geria where it was 29.6% [9]. Self-reported allergic rhinitis in our study (11.4%) was within the
range of reports from other parts of the world: 13.1% in Europe (ranging from 11.1% in Italy to
16.2% in Germany), 14% in USA, 7% in Latin America and 9% in Asia Pacific [42,43]. In addi-
tion to the classical association between allergic rhinitis and other allergic conditions, smoking
and higher education were more frequent in our participants with allergic rhinitis. The high
prevalence of allergic rhinitis among smokers was also reported by Desalu et al [9], but in a re-
cent meta-analysis by Saulyte et al, there was no association between current or past tobacco
use and allergic rhinitis in adults [44]. Studies have been conflicting on the association between
socio-economic status (SES) and allergic rhinitis. Some studies have suggested higher preva-
lence of allergic rhinitis in people with high SES [9,45], while other have found not association
[46].
The main limitation of this study resides in the use of screening questionnaire to diagnose
asthma and allergic rhinitis. This approach is subject to recall bias, but our questionnaire was
adapted from internationally validated questionnaires, and which have been used in most sur-
veys around the world, therefore allowing our results to be comparable with those from the
many other studies with similar methodological approaches [18,19]. It is possible that using
spirometry (to characterise the reversibility and non-specific bronchial hyperreactivity) and
allergologic tests would have refined the description of the prevalence in our study. The large
sample size is a major strength of the current study, and has allowed us to derive stable esti-
mates of disease occurrence.
Conclusion
Prevalent asthma and allergic rhinitis in this major central African city occurred at frequencies
in the lower tails of reports from around the world. A large proportion of participants with
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severe wheezing does not receive treatment in this setting and are therefore at risk of fatal out-
come. In addition to the classical association between allergic diseases which was confirmed in
our study, tobacco use and education were independent correlates of symptoms of allergic rhi-
nitis. A nationwide survey will aid the refinement of our finding and investigate within country
variations in the prevalence of asthma in Cameroon.
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